Stock Market News

Ranbaxy Q1 by Epic Research

Consolidated Net Loss At Rs 186 Crore Versus Loss Of Rs 524.2 Crore (YoY)

Consolidated Revenue At Rs 2,426.2 Crore Versus Rs 2,634.2 Crore (YoY)

Consolidated EBITDA At Rs 238 Crore Versus Rs 200 Crore (YoY)

Consolidated Operating Margin At 9.8 percent Versus 7.6 percent (YoY)

Consolidated Settlement Provision At Rs 237.7 Crore

Real Time News & Trading Trends Keep Liking #EpicResearch

Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+

For more information ✆ – 0731-6642300 or Visit

Share Button
Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300